Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic
Go back to Plus Therapeutics Receives Medicare Enrollment Approval for CNSide Diagnostic| (NASDAQ: PSTV) | Delayed: 3.83 +0.05 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.78 | 52 Week High | $ | |||
| Open | $3.81 | 52 Week Low | $ | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $3.81 | EPS | $ | |||
| Volume | 61,339 | |||||
